99 related articles for article (PubMed ID: 11310585)
1. Identification and allelic frequencies of novel single-nucleotide polymorphisms in the DUSP1 and BTG1 genes.
Suzuki C; Unoki M; Nakamura Y
J Hum Genet; 2001; 46(3):155-7. PubMed ID: 11310585
[TBL] [Abstract][Full Text] [Related]
2. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
3. Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
Obata K; Morland SJ; Watson RH; Hitchcock A; Chenevix-Trench G; Thomas EJ; Campbell IG
Cancer Res; 1998 May; 58(10):2095-7. PubMed ID: 9605750
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas.
Lin WM; Forgacs E; Warshal DP; Yeh IT; Martin JS; Ashfaq R; Muller CY
Clin Cancer Res; 1998 Nov; 4(11):2577-83. PubMed ID: 9829719
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity phosphatase 1 and serum/glucocorticoid-regulated kinase are downregulated in prostate cancer.
Rauhala HE; Porkka KP; Tolonen TT; Martikainen PM; Tammela TL; Visakorpi T
Int J Cancer; 2005 Dec; 117(5):738-45. PubMed ID: 15981206
[TBL] [Abstract][Full Text] [Related]
6. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
Maxwell GL; Risinger JI; Tong B; Shaw H; Barrett JC; Berchuck A; Futreal PA
Gynecol Oncol; 1998 Jul; 70(1):13-6. PubMed ID: 9698466
[TBL] [Abstract][Full Text] [Related]
7. A mammalian expression system for rapid production and purification of active MAP kinase phosphatases.
Chen P; Hutter D; Liu P; Liu Y
Protein Expr Purif; 2002 Apr; 24(3):481-8. PubMed ID: 11922765
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.
Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C
Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387
[TBL] [Abstract][Full Text] [Related]
9. CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potential.
Manzano RG; Montuenga LM; Dayton M; Dent P; Kinoshita I; Vicent S; Gardner GJ; Nguyen P; Choi YH; Trepel J; Auersperg N; Birrer MJ
Oncogene; 2002 Jun; 21(28):4435-47. PubMed ID: 12080474
[TBL] [Abstract][Full Text] [Related]
10. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
[TBL] [Abstract][Full Text] [Related]
12. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
[TBL] [Abstract][Full Text] [Related]
13. Allelic imbalance and mutations of the PTEN gene in ovarian cancer.
Saito M; Okamoto A; Kohno T; Takakura S; Shinozaki H; Isonishi S; Yasuhara T; Yoshimura T; Ohtake Y; Ochiai K; Yokota J; Tanaka T
Int J Cancer; 2000 Jan; 85(2):160-5. PubMed ID: 10629071
[TBL] [Abstract][Full Text] [Related]
14. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
15. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock.
Hammer M; Mages J; Dietrich H; Servatius A; Howells N; Cato AC; Lang R
J Exp Med; 2006 Jan; 203(1):15-20. PubMed ID: 16380512
[TBL] [Abstract][Full Text] [Related]
16. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
17. Identification of a pseudogene that can masquerade as a mutant allele of the PTEN/MMAC1 tumor suppressor gene.
Whang YE; Wu X; Sawyers CL
J Natl Cancer Inst; 1998 Jun; 90(11):859-61. PubMed ID: 9625175
[No Abstract] [Full Text] [Related]
18. PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas.
Chiariello E; Roz L; Albarosa R; Magnani I; Finocchiaro G
Oncogene; 1998 Jan; 16(4):541-5. PubMed ID: 9484844
[TBL] [Abstract][Full Text] [Related]
19. Phosphatases and tumorigenesis.
Parsons R
Curr Opin Oncol; 1998 Jan; 10(1):88-91. PubMed ID: 9466490
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
Marsh DJ; Dahia PL; Zheng Z; Liaw D; Parsons R; Gorlin RJ; Eng C
Nat Genet; 1997 Aug; 16(4):333-4. PubMed ID: 9241266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
